ReviewTranslational cancer research2019

Anaplastic lymphoma kinase tyrosine kinase inhibitors in non-small cell lung cancer.

Tiziana Vavalà et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.